Skip to main content
OpenTrials
Completed

NCT Number: NCT03203213

Musitox® Project: Consumption of Psychoactive Substances at Music Festivals in Aquitaine

Poisoning by psychoactive substances is increasingly common in Europe and can be responsible for deaths. These substances, also called "festive drugs", circulate among other places in festive gatherings (night clubs, concerts, free music, feria, etc.). The main objective of this study is to determine the molecules that circulate in festive events in Aquitaine, in order to implement prevention actions by looking at whether the circulating substances vary with the style of event.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital Pellegrin

Bordeaux, 33076, France

About this study

Poisoning by psychoactive substances is increasingly common in Europe and can be responsible for deaths. These substances, also called "festive drugs", circulate among other places in festive gatherings (night clubs, concerts, free music, feria, etc.).

There is also a significant increase in the number of new psychoactive substances (NSPs) whose toxicity is unknown: by 2014, 101 new substances were detected for the first time in Europe. These molecules, because of this regular and rapid emergence, are not included in the narcotics list, in the great majority of cases.

Poison control centers, as well as addictovigilance centers, are regularly called upon for serious poisoning resulting in hospitalization, for which analytical evidence is most often missing or difficult to obtain. The lack of documentation, both analytical and clinical, of these files limits its expertise. As a result, medical knowledge, in particular clinical knowledge, progresses little which limits the efficiency of the management of these poisonings.

A 2015 pilot study on the Dax and Mont-de-Marsan (FERIATOX) fertilization sites on 27 patients showed that although several psychoactive substances have been identified in these patients (cocaine, ketamine, MDMA, cannabis, etc.) No DK was identified in this study. It is possible, however, that the profile of people who frequent ferias is different from that of music festivals, which explains the lack of identification of these substances in the FERIATOX study. To support this hypothesis, it seems important to renew this study on festive events of the type of music festival. The Garorock Festival (Marmande), held at the beginning of July, seems to be relevant for the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any patient admitted to the Emergency Medical Post with neurological and / or behavioral disorders:
  • agitated at the time of admission to the PMA or during surveillance at the LDC
  • and who will say (or for whom his entourage will say that he has) consumed psychoactive substances
  • or who will be unable to say that they have taken a psychoactive substance and for which no other etiology is evident
  • and / or for which the seriousness of the case necessitates admission to the emergency or intensive care, whether or not the physician is aware of a psychoactive substance (and in the absence of an obvious etiology)
  • and / or if the PMA physician considers that analytical research is needed for further care
  • Oral Express Consent
  • any patient who is in possession of an identity document proving his / her majority (over 18 years).

Exclusion criteria

  • Refusal of the patient to take a sample, or to participate in the study
  • Minors (under 18 years of age)
  • Pregnant women
  • Breastfeeding women
  • Patient who can not prove his / her age by the production of an identity document.

Treatment and study plan

Sampling of a few drops of blood, lock of hair and urine

Procedure

Sampling of a few additional drops of blood to deposit them on blotting paper (DBS: Dried Blood Spot) ad hoc and to send this sample for analysis and identification of a possible toxic cause by psychoactive substance in relation to the clinical picture presented by the patient. An oriented capillary sampling is also performed if possible. Similarly a urine sample is taken if possible.

Primary outcomes

  1. Number of patients who have consumed new psychoactive substances

    Time frame: baseline

    Number of patients who have consumed new psychoactive substances

Secondary outcomes

  1. number of toxidomas observed clinically

    Time frame: Baseline

    number of toxidomas observed clinically

  2. number of patients who have previously used new psychoactive substances (hair, urine

    Time frame: Baseline

    number of patients who have previously used new psychoactive substances (hair, urine

  3. number of classes of new psychoactive substances found in the analyzes

    Time frame: baseline

    number of classes of new psychoactive substances found in the analyzes

  4. severity evaluated secondarily from the clinical data sheets and according to poisoning severity score

    Time frame: baseline

    severity evaluated secondarily from the clinical data sheets and according to poisoning severity score

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Collaborators

  • Regional Health Agency New Aquitaine

Registry information

Acronym: Musitox®

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jun 29, 2017
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.